Come up with a name for your new list and we'll add to it:
U3 Pharma Ag was acquired by
Daiichi Sankyo on May 21, 2008.
U3 Pharma AG is involved in targeted cancer drug development. The Company is advancing a portfolio of novel antibody-based therapeutics that will be used as mono therapies and combination therapies fo…